Clinical Phenotypes Characterization in Pharmacogenetics Testing Trials for Major Depressive Disorder Treatment

被引：0
|
作者：
Minelli, A. [1 ]
机构：
[1] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy
来源：
EUROPEAN PSYCHIATRY | 2022年 / 65卷
关键词：
Pharmacogenetic test; antidepressant; major depressive; disorder; Personalized medicine;
D O I：
10.1192/j.eurpsy.2022.137
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
S0084
引用
收藏
页码：S39 / S40
页数：2
相关论文
共 50 条
  • [1] SSRIs pharmacogenetics and clinical outcome in the treatment of major depressive disorder
    Lee, M. S.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S76 - S76
  • [2] Pharmacogenetics of major depressive disorder
    Lohoff, Falk W.
    [J]. PSYCHIATRIC ANNALS, 2008, 38 (06) : 414 - 418
  • [3] Catechol-O-Methyltransferase (COMT) Pharmacogenetics in the Treatment Response Phenotypes of Major Depressive Disorder (MDD)
    Kocabas, Neslihan Aygun
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (03) : 264 - 272
  • [4] The role of pharmacogenetics in the treatment of major depressive disorder: a critical review
    Barlati, Stefano
    Minelli, Alessandra
    Nibbio, Gabriele
    Bertoni, Lorenzo
    Necchini, Nicola
    Paolini, Stefano
    Muscarella, Alessia
    Ubertino, Ughetta Bosco
    Calzavara-Pinton, Irene
    Vita, Antonio
    Gennarelli, Massimo
    [J]. FRONTIERS IN PSYCHIATRY, 2023, 14
  • [5] Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder
    Leuchter, Andrew F.
    Hunter, Aimee M.
    Krantz, David E.
    Cook, Ian A.
    [J]. DIALOGUES IN CLINICAL NEUROSCIENCE, 2014, 16 (04) : 525 - 537
  • [6] Pharmacogenetics of Major Depressive Disorder: Top Genes and Pathways Toward Clinical Applications
    Fabbri, Chiara
    Serretti, Alessandro
    [J]. CURRENT PSYCHIATRY REPORTS, 2015, 17 (07)
  • [7] Pharmacogenetics of Major Depressive Disorder: Top Genes and Pathways Toward Clinical Applications
    Chiara Fabbri
    Alessandro Serretti
    [J]. Current Psychiatry Reports, 2015, 17
  • [8] The Clinical Utility of Pharmacogenetic Testing in Major Depressive Disorder
    Riggs, Ashlee Rickard
    [J]. US PHARMACIST, 2020, 45 (05) : HS11 - HS14
  • [9] Citalopram and escitalopram in the treatment of major depressive disorder: A pooled analysis of 3 clinical trials
    Li, Huafang
    Li, Ting
    Li, Guanjun
    Luo, Jianfeng
    [J]. ANNALS OF CLINICAL PSYCHIATRY, 2014, 26 (04) : 281 - 287
  • [10] Duloxetine for the treatment of major depressive disorder. A review of phase III clinical trials
    Arrazola Saniger, M.
    Castells Molina, S.
    Ogayar Luque, M.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 99 : 27 - 27
12345